title: Effect of varying amino acid levels on protein metabolism in nephrotic rats during total parenteral nutrition.
abstract: In an attempt to determine appropriate diet in nephrotic syndrome, nephrotic rats, induced by puromycin aminonucleoside, were nourished by total parenteral nutrition fluid containing the same energy, but three different levels (1.65, 3.3, and 6.6%) of amino acids for 7 d. The fractional rate of total protein synthesis in the liver was determined by injecting a flooding dose of [3H]phenylalanine. The proportion of newly synthesized proteins retained and exported by the liver was estimated by injecting a tracer dose of [14C]leucine and then measuring the protein radioactivity remaining in the liver and present in the plasma after secretion was completed. Nephrotic animals synthesized more protein than control animals. Although the absolute synthesis rates of total protein in liver were increased with increasing amino acid administration, the absolute rates of synthesis of albumin were higher in the 3.3% group than in the other groups in nephrotic rats. However, kidney protein synthesis in nephrotic rats was higher in the 1.65% group than in the 3.3% group. Interestingly, the 3.3% group revealed the smallest urinary excretion of total protein and albumin. In addition, in the 3.3% group, plasma concentrations of total protein and albumin were higher, and plasma concentrations of total cholesterol and triglyceride were lower than in other groups. It was concluded that the 3.3% group, corresponding to a normal protein diet, has the greatest salutary effect on urinary protein excretion, followed by protein and lipid metabolism, in nephrotic rats. Not only protein intake but also the energy:protein ratio are important for diet therapy in nephrotic animals. The technique of total parenteral nutrition may be useful in defining the factors involved in glomerular permeability or permselectivity and intracellular protein metabolism.
authors.affiliation: Department of Medicine, Tokyo Women's Medical College, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Kawashima
authors.forename: K
authors.initials: K
authors.lastname: Chiku
authors.forename: M
authors.initials: M
authors.lastname: Kawashima
authors.forename: K
authors.initials: K
authors.lastname: Nitta
authors.forename: W
authors.initials: W
authors.lastname: Yumura
authors.forename: N
authors.initials: N
authors.lastname: Sugino
authors.forename: H
authors.initials: H
authors.lastname: Nihei
authors.forename: Y
authors.initials: Y
authors.lastname: Natori
mesh_terms: D000596:Amino Acids / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D004305:Dose-Response Relationship, Drug; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D009401:Nephrosis / Q000378:metabolism* / Q000628:therapy*; D009752:Nutritional Status; D010289:Parenteral Nutrition, Total; D010649:Phenylalanine / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000596:Amino Acids; D011506:Proteins; D010649:Phenylalanine